Jonathan Butcher

[BioVersys @Bioversys]

#BioVersys announces that it has entered into an exclusive ansamycin drug discovery collaboration and license agreement with Hackensack Meridian Health. https://t.co/CNtPc6ndRz
@HMHNewJersey @UMNews #HealthCareInnovation #Collaboration #AMR #Antibiotics #InfectiousDiseases

[BioVersys @Bioversys]

📡 BioVersys Receives Green Light from US FDA for BV100 HABP/VABP Phase 3 Pivotal Trial Start.
See: https://t.co/tdor3GSBWH
#SavingLivesInResistantTimes #HealthcareInnovation #AMR #biotech #antibiotics #CRAB

[BioVersys @Bioversys]

BioVersys Announces First Patient Dosed in Phase 2b Clinical Trial of AlpE in Pulmonary Tuberculosis. https://t.co/qTbyiBIdc7
@GSK @IHIEurope @UNITE4TB @EFPIA Deutsches Zentrum für Infektionsforschung (#DZIF), @LMU_Muenchen German Federal Ministry of Education and Research

[BioVersys @Bioversys]

📡 Meet BioVersys at the world renowned Gordon Research Conference, on New Antibacterial Discovery and Development on March 8-13, Lucca, Italy, to talk about our TB program in Phase 2.
https://t.co/NyQwz8lYP9
@EDCTP @GSK @taskapplied @IHIEurope @univ_lille @PasteurLille

[BioVersys @Bioversys]

📡 BioVersys and partners’ Phase 2a tuberculosis trial results published in New England Journal of Medicine
@EDCTP @GSK @taskapplied @bEtoTB1 @NEJM
https://t.co/TBQiPMJlEf

[BioVersys @Bioversys]

🚀More exciting progress and success in funding BioVersys programs - with BV100 Phase 2B to be conducted via Wellcome Funded Trial Network.
Link to full press release: https://t.co/5B4ibHLDkM

[BioVersys @Bioversys]

📡 @Bioversys and @SHIONOGI_JP, enter into Global Research Collaboration for broad-spectrum NTM clinical candidates. Read more here: https://t.co/BtNb9pTwPi

[BioVersys @Bioversys]

Click https://t.co/kFuD18KsiL for an informative KOL event; May 7, 2025, 8:30 AM ET / 2:30PM CEST. Featuring Professor David Paterson & Dr. Andrew Shorr, MD, discussing the unmet need & current treatment landscape for carbapenem resistant Acinetobacter baumannii pneumonia. #AMR

[Jonathan Butcher @SwissButcher74]

If you’re going to ⁦@ESCMID⁩ Global 2025 in Vienna this month make sure to see the oral and poster presentations from ⁦⁦@Bioversys⁩ https://t.co/69gnk5356c

[BioVersys @Bioversys]

BioVersys announces joining the @AMRAccelerator EU-funded programme @RespiriNTM, access to up to €2 m in non-dilutive funding for our broad-spectrum NTM project. Read the full press release here: https://t.co/zFUoKAuQtY
#SavingLivesinResistantTimes #AMR #investment #Innovation

[BioVersys @Bioversys]

📡 Exciting times as BioVersys announces last patient, last visit in the Phase 2 clinical trial with BV100 showing positive first signs of efficacy for #VABP #CRAB. 🎯🌍 🏥
🚀 Read the full press release here: https://t.co/SCom3zT3fm
#SavingLivesinResistantTimes #AMR #Innovation

[BioVersys @Bioversys]

BioVersys announces strategic investment from GIBF2 and launch of BV100 clinical program in China.
· GIBF2 to invest US$ 6m in BioVersys
· BV100 Phase 1 study in China expected to start in 1H 2025
Press release: https://t.co/dubXVfOl6m
#AMR #investment #China #Innovation

[Jonathan Butcher @SwissButcher74]

@euroairportcom please make sure to train the staff to take care of directing people to the biometric passport control - it was not good coming through @BSL_MLH_Airport today because of the lack of organization and lots of people!!

[BioVersys @Bioversys]

#PassThePasteurAct

[Jonathan Butcher @SwissButcher74]

⁦@BBCSport⁩ - more speed and better pressing and support for Kane - stop all this dropping deep.

[talkSPORT @talkSPORT]

🎶 Can’t start a fire,
Can’t start a fire without a spark,
Phil Foden’s on Fire…
He’ll be playing the Germans off the park”

England fans have a new song ready for tomorrow’s game against Serbia! 🎤 🔥

[BioVersys @Bioversys]

BioVersys announces expansion of collaboration with GSK and extension of Series C (CHF 12.3m) to CHF 44.9m. BioVersys strives to bring urgently needed medicines to patients, with strong partners, @GSK, & loyal investors, we're firmly on track.🌍💊
Full PR: https://t.co/2uGXMNt8RN

[Venture Kick @venturekick]

CHF 12.3 million to boost novel drugs against tuberculosis: TOP 100 Swiss scale-up @Bioversys secures its Series C and expands collaboration with GSK.
Congrats to the world-class team led by biotech pioneers Marc Gitzinger, Sergio Lociuro, and Glenn Dale!
https://t.co/PYVFbjt7Zz

[Jonathan Butcher @SwissButcher74]

@easyJet the Euro Airport Basel has been evacuated! Please can you follow this and provide information to EasyJet customers like me on what is happening . We are stuck outside the building with no information!

[Jonathan Butcher @SwissButcher74]

@BSL_MLH_Airport The @BSL_MLH_Airport has just been evacuated for security reasons and hundreds of people are waiting outside for news of what’s happening!!